scholarly journals ASSESSMENT OF MEDICATION ERRORS IN PEDIATRICINPATIENT DEPARTMENT OF A PRIVATE HOSPITAL

Author(s):  
P. Nikhithasri ◽  
M. Ramya ◽  
P. Kishore

Objective: To assess the overall rate and incidence of medication errors in pediatric inpatients and to determine the importance of pharmacist participation in medication errors.Methods: A prospective observational study has been conducted in a ‘private childrens hospital’ for 6 mo at Warangal, Telangana. Patients who are ≤18 ywere considered. Data was collected from patient records, direct communication with patient and their care givers.Results: Among 400 patients with 2,461 medication orders,1381(56%) errors were found. Patients were more exposed to AME(33.7) caused by the nursing staff, followed by PME-21.5,CME-0.6,DME-0.2 in incidence with the 95% CI.Conclusion: Pediatric patients are more exposed to administration errors and prescribing errors. Pediatricians and Pharmacists should develop effective programs for safe administration of medications, report medication errors, eliminate barriers in reporting medication errors, encourage a non-punitive reporting culture and create an environment of medication safety for all hospitalized pediatric patients

2019 ◽  
Vol 9 (6-s) ◽  
pp. 103-106
Author(s):  
Peddolla Sushma Reddy ◽  
Vidya Biju ◽  
Inuganti Bhavana

Background: Medication error is defined as any avertable event that may cause or lead to inappropriate medication use or patient harm while the medication is in the control of the health care professional, patient and consumer. Medication errors may occur at any stage of the medication use process including ordering, transcription, dispensing, administering and monitoring.  Objective: The objective of the study is to assess the medication errors in a tertiary care hospital and to categorize them based on their nature and type. Methodology: A prospective observational study was conducted over a period of 3 months in a tertiary care teaching hospital. This study was carried out among 240 inpatients, admitted in General Medicine department of the hospital, who were selected randomly. During the study, inpatients case records were reviewed, which includes patient’s case history, diagnosis, medication order sheets, progress chart, laboratory investigations. The data collected were analyzed for identifying medication errors such as prescribing errors and administration errors. Each reported medication error was assessed using the National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP) proposed index for categorizing medication errors. Results: A total number of 240 inpatients were enrolled in the study, out of which 82 patients have developed medication errors. The overall percentage of observed medication error was 34.16%. In our study medication errors were found more in males (70.7%) than in the females (29.3%). Prescribing errors (62.19%) were the most frequently occurring type of error, which was followed by administration errors (37.8%). In our study, we found that medication errors were more with antibiotics (37) followed by NSAIDs (19). 96 prescriptions were found having drug interactions. Conclusion: This study concludes that the overall incidence of medication error was found to be 34.16%. Most of the medication errors are clinically significant and it can prevent by working together in a health care team.  


This case focuses on medication errors and adverse drug events occurring during the perioperative period by asking the question: What are the rates, types, severity, and preventability of medication errors (MEs) and adverse drug events (ADEs) in the perioperative setting during anesthesia care? This prospective observational study reported that approximately 1 in 20 perioperative medication administrations, and every second operation, resulted in an ME and/or an ADE. These rates are markedly higher than those reported by prior retrospective surveys. Process- and technology-based solutions may address the root causes of MEs to reduce their incidence.


2008 ◽  
Vol 51 (4) ◽  
pp. 517-520 ◽  
Author(s):  
Leslie Raffini ◽  
Anne Marie Cahill ◽  
Jeffrey Hellinger ◽  
Catherine Manno

2020 ◽  
Vol 09 (02) ◽  
pp. 093-100 ◽  
Author(s):  
Evelina Maines ◽  
Elisa Tadiotto ◽  
Grazia Morandi ◽  
Michela Fedrizzi ◽  
Rossella Gaudino ◽  
...  

AbstractThe use of intravenous bisphosphonates has been linked to hypocalcemia both in children and adults with osteogenesis imperfecta (OI). The aims of this study were: (1) to investigate the incidence of hypocalcemia in the first 48 hours (T48) after neridronate infusion in a pediatric population with OI and (2) to assess any correlation between the baseline values of calcium, vitamin D (25-hydroxyvitamin D) and bone turnover markers, and the postinfusion calcium values. We conducted a prospective observational study on 37 pediatric patients. All patients were treated with a single infusion of neridronate at a dose of 1 to 2 mg/kg. The study provided two postinfusion reassessments: 24 hours (T24) and T48 after neridronate administration. Hypocalcemia was observed in 11% of patients at T24 and in 50% of patients at T48 from neridronate infusion. We observed a positive linear correlation between the baseline vitamin D values and postinfusion calcium values, both at baseline and at T24 and T48. Hypocalcemia was mild and asymptomatic in all cases. Postinfusion calcium levels were related to baseline vitamin D levels. Consequently, low vitamin D levels should be considered a significant risk factor for hypocalcemia and should be carefully investigated and treated before neridronate infusion.


Sign in / Sign up

Export Citation Format

Share Document